Vaccine for cervical cancer prevention to be available in small quantity in 2023, increased next year: Adar Poonawalla

By Shalini BhardwajNew Delhi [India], January 25 (ANI): A day after the launch of the first made-in-India Human Papillomavirus (HPV) "CERVAVAC" vaccine for the prevention of cervical cancer, Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla on Wednesday said that the availability of the vaccine will be little in number this year, however, it would be boosted next year.

Poonawalla briefed Union Hea